Clinical Trials Directory

Trials / Unknown

UnknownNCT03502889

Single Dose Adductor Canal Block vs SPANK Block for TKA

Single Dose Adductor Canal Block With SPANK (Sensory Posterior Articular Nerves of the Knee) Block Compared to Single Dose Adductor Canal Block and Pain Control After Total Knee Arthroplasty

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
128 (estimated)
Sponsor
San Antonio Uniformed Services Health Education Consortium · Federal
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is a prospective, randomized control trial to compare SPANK block combined with adductor canal block to adductor canal block alone in treatment of post-operative pain after total knee arthroplasty. The primary outcome is pain control, which will be measured throughout the post-operative course using morphine equivalents of opioid analgesics used during the first 24 hours after surgery. Secondary outcomes include pain scores recorded at 4, 8, 12, 16, 20, and 24 hours post-operatively, cumulative pain score, incidence of post-operative nausea and vomiting, and extent of motor blockade. The study will aid in answering the question of whether SPANK block is an effective adjunct in preventing pain and decreasing opioid requirement after TKA.

Conditions

Interventions

TypeNameDescription
PROCEDURESPANK Block (Sensory Posterior Articular Nerves of the Knee)Injection of local anesthetic into the tissues on the posterior aspect of the knee to provide sensory blockade of the articular nerves of the knee.
PROCEDUREAdductor Canal BlockInjection of local anesthetic into the inner thigh under ultrasound guidance to provide sensory blockade to the anterior aspect of the knee
DRUGRopivacaine Hcl 0.5% Inj Vil 30MlAmide local anesthetic, this concentration is commonly used to achieve surgical level anesthesia. The drug itself is not being studied and the same concentration will be used in all participants.
DEVICEPajunk sonoplex stim needleEchogenic needle used for ultrasound guided nerve blockade.

Timeline

Start date
2019-06-01
Primary completion
2020-04-01
Completion
2020-06-01
First posted
2018-04-19
Last updated
2019-04-16

Source: ClinicalTrials.gov record NCT03502889. Inclusion in this directory is not an endorsement.